Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses
NCT06052956Phase 2Not yet recruiting
- Sponsor
- University of Rochester
- Start
- Jul 2026
- Primary completion
- Jun 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue in abscess, sponsored by University of Rochester. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
methylene blue
03
Conditions
abscess
Beyond the preview
Go deeper on NCT06052956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06052956.